APEA Endo Questions and Correct Solutions 2024

APEA Endo Questions and Correct Solutions 2024 When patients administer regular insulin (Humulin R U-500), they should be taught: - Answer -10 units of Humulin R U-500 is equal to 10 units on a U-500 insulin syringe. Radioiodine therapy is safe to administer to: - Answer -A 30-year-old man who desires natural fatherhood-used to tx hyperthyroidism and does not cause infantility or birth defects in the offspring of tx'd pts A pt who has Addison's disease has received a prescription for fludrocortisone. Fludrocortisone acts by: - Answer -Regulating salt and water balance-mineralocorticoid indicated as partial replacement therapy for pts with primary or 2ndary adrenocortical insufficiency Methimazole for the tx of Graves' disease is contraindicated in pts: - Answer -Who are pregnant-can cause fetal harm when administered, can readily cross the placental membranes Which of the following medications may cause gynecomastia? - Answer -Enalapril (Vasotec)-ACE inhibitors may cause gynecomastia A pt is started on a sulfonylurea (i.e. glyburide). The NP informs the pt that sulfonylureas are likely to: - Answer -Reduce microvascular events-also low in cost Disadvantages-produce hypoglycemia and cause weight gain Thiazolidinedione (TZD) medications: - Answer -Increase insulin sensitivity-by acting on adipose, muscle & liver to increase glucose utilization and decrease glucose production Pts taking dipeptidyl-peptidase-4 (DDP-IV) inhibitors for the tx of T2DM do NOT routinely need to be monitored for: - Answer -Weight loss-Januvia, Onglyza, Tradjenta not likely to cause weight loss or weight gain The expected hemoglobin A1V reduction for pts who are started on dipeptidyl-peptidase-4 (DDP-IV) inhibitors such as sitagliptin (Januvia) is: - Answer -0.6% DDP-IV inhibitors such as alogliptin (Nesina): - Answer -Suppress glucagon secretion and increase insulin secretion Sulfonylurea-stimulate the release of insulin from functioning beta cel